Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The study will demonstrate the effect of 24 weeks of treatment with vildagliptin compared to
placebo on insulin sensitivity in patients with type 2 diabetes mellitus (T2DM) treated with
metformin, assessed as glucose Rd (rate of glucose disposal) during a hyperinsulinemic
euglycemic clamp.